Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies
Therapeutic Advances in Gastrointestinal Endoscopy · 2021-01 · 14
DOI: 10.1177/2631774521993065 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Therapeutic Advances in Gastrointestinal Endoscopy, online erschienen am 10.02.2021. Verfasst von Lei Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary, Pancreatic and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical Co…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Data on prognostic factors associated with outcome following resection of perihilar cholangiocarcinoma vary. We sought to define and characterize current available evidence on prognostic factors associated with perihilar cholangiocarcinoma after resection. The PubMed, Embase, and Cochrane library were systematically searched for relevant studies published before December 2019. Prognostic factors were identified from multivariate regression analyses in studies. Only high-quality studies were included (Newcastle–Ottawa Scale > 6 stars). A total of 45 studies involving 7338 patients were analyzed. The meta-analysis demonstrated that serum bilirubin levels (hazard ratio: 1.76, 95% confidence interval: 1.27–2.44), serum CA19-9 levels (hazard ratio: 1.32, 95% confidence interval: 1.05–1.65), tumor size (hazard ratio: 1.27, 95% confidence interval: 1.04–1.55), major vascular involvement (hazard ratio: 1.61, 95% confidence interval: 1.09–2.38), distance metastasis (hazard ratio: 17.60, 95% confidence interval: 2.01–154.09), perioperative blood transfusion (hazard ratio: 1.36, 95% confidence interval: 1.15–1.62), T-stage (hazard ratio: 1.96, 95% confidence interval: 1.47–2.61), lymph node metastasis (hazard ratio: 2.06, 1.83–2.31), resection margin status (hazard ratio: 2.34, 95% confidence interval: 1.89–2.89), not-well histology differentiation (hazard ratio: 2.03, 95% confidence interval: 1.69–2.44), perineural invasion (hazard ratio: 2.37, 95% confidence interval: 1.59–3.55), and lymphovascular invasion (hazard ratio: 1.41, 95% confidence interval: 1.15–1.73) were prognostic factors for poorer overall survival. Adjuvant chemotherapy (hazard ratio: 0.37, 95% confidence interval: 0.25–0.55) had a positive effect on prolonged overall survival. In addition, positive resection margin status (hazard ratio: 1.96, 95% confidence interval: 1.47–2.61) and lymph node metastasis (hazard ratio: 2.06, 95% confidence interval: 1.83–2.31) were associated with poorer disease-free survival. The prognostic factors identified in the present meta-analysis can be used to characterize patients in clinical practice and enrich prognostic tools, which could be included in future trial designs and generate hypotheses to be tested in future research to promote personalized treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary, Pancreatic and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
- Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, China.
- Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
- Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Hangzhou, China.
- Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, China.
ORCID-Profile: Lei Liang, Hang-Dong Jia, Tian Yang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liang, L., Li, C., Jia, H. D., Diao, Y. K., Xing, H., Pawlik, T. M., Lau, W. Y., Shen, F., Huang, D. S., Zhang, C. W., & Yang, T. (2021). Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Therapeutic Advances in Gastrointestinal Endoscopy, 14. https://doi.org/10.1177/2631774521993065
Vancouver
Liang L, Li C, Jia HD, Diao YK, Xing H, Pawlik TM, et al. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Therapeutic Advances in Gastrointestinal Endoscopy. 2021;14. doi:10.1177/2631774521993065
BibTeX
@article{Liang2021,
author = {Liang, Lei and Li, Chao and Jia, Hang-Dong and Diao, Yong-Kang and Xing, Hao and Pawlik, Timothy M and Lau, Wan Yee and Shen, Feng and Huang, Dong-Sheng and Zhang, Cheng-Wu and Yang, Tian},
title = {Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies},
journal = {Therapeutic Advances in Gastrointestinal Endoscopy},
year = {2021},
volume = {14},
doi = {10.1177/2631774521993065}
}
EUVIMED